dsm-firmenich Restates Financials After Animal Nutrition Divestment
Event summary
- dsm-firmenich has reclassified Animal Nutrition & Health (ANH) as Discontinued Operations following its divestment to CVC Capital Partners.
- Financial results for 2024 and 2025 have been restated to reflect the new reporting structure, with comparative figures provided for Q4 2024 through Q3 2025.
- Key adjustments include the transfer of Bovaer to Taste, Texture & Health and Veramaris to Health, Nutrition & Care.
- The company will introduce an updated 'Core EBIT' metric to facilitate peer comparisons, adding back merger-related amortisation and PPA intangible asset amortisation.
- Nutrition Improvement activities will shift from Health, Nutrition & Care to Group Sustainability starting Q1 2026, generating €20 million in quarterly net sales.
The big picture
dsm-firmenich's divestment of ANH and subsequent financial restatement reflect a broader industry trend of portfolio streamlining to focus on core competencies. The move aligns with the company's 2024 Capital Markets Day commitments, signaling a strategic pivot towards higher-margin segments like Perfumery & Beauty and Health, Nutrition & Care. The introduction of 'Core EBIT' underscores the company's efforts to enhance transparency and comparability amid a complex post-merger integration landscape.
What we're watching
- Integration Challenges
- How the transfer of key products like Bovaer and Veramaris will impact operational efficiency and revenue streams within their new segments.
- Financial Metrics
- Whether the introduction of 'Core EBIT' will provide clearer insights into dsm-firmenich's ongoing performance and facilitate better peer comparisons.
- Sustainability Focus
- The pace at which the shift of Nutrition Improvement activities to Group Sustainability will influence the company's ESG metrics and investor perception.
Related topics